From our Swiss qualitative study with pharma leaders: decision-making has narrowed in horizon, slowing cross-functional execution and increasing rework. Layer in frequent reorganisations, budget constraints, and digitalisation (incl. AI), and a 2026 performance risk comes into focus: employee engagement drops before results do.

Join our free 40-minute session designed for HR leaders, HRBPs, L&D / People & Org Development, and department heads who want a clear way to check if these patterns are present in their organisation—and what to do next.

Can’t attend live? Register to receive the recording and the insights deck.

This isn’t a sales pitch. We ran this study for ourselves—pharma is one of Bevel’s core practice areas—and the findings were strong enough to share openly. Come hear what we found, pressure-test it against your reality, and help refine the 2026 forecast with industry peers who understand how team engagement directly drives business performance.

Not in pharma?…